Grandmother's cancer can be treated with two daily tablets

A 71-year-old grandmother with stage four lung cancer is successfully managing her condition with targeted daily tablets following a genetic blood test. This approach represents a shift toward personalized medicine over traditional chemotherapy.
Why it matters
Advances in genetic testing and targeted therapies are significantly improving quality of life and treatment outcomes for cancer patients.
Image caption, Christina Isik suddenly fell ill while on holiday in Turkey
A grandmother with stage four lung cancer says she is looking forward to enjoying life after discovering it could be controlled with just two daily tablets.
Christina Isik, 71, from Hindley in Greater Manchester, was on holiday with her husband in Turkey two years ago when she suddenly fell ill.
Using a cutting-edge blood test, scientists have found Christina's cancer has a genetic mutation which allows her to be treated with tablets rather than more conventional techniques like chemotherapy.
A lab in Manchester is now managing the blood test for the whole of the north of England.
Christina was told her diagnosis after she returned home for medical treatment.
"It was awful, just awful. I just cried," she said.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in